Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_assertion type Assertion NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_head.
- NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_assertion description "[In this study, we compared the capacity of DC loaded with wild-type versus modified gp100 peptides with higher binding affinities to induce an immune and clinical response in advanced melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_provenance.
- NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_assertion evidence source_evidence_literature NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_provenance.
- NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_assertion SIO_000772 21069321 NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_provenance.
- NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_assertion wasDerivedFrom befree-2016 NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_provenance.
- NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_assertion wasGeneratedBy ECO_0000203 NP851824.RACFj-JefTo_f6GIjEfJQFxKj33q6s-htf7cJnHHkydC4130_provenance.